Ontology highlight
ABSTRACT: Introduction
Histiocytic sarcoma (HS) is a rare and aggressive hematologic malignancy with a poor prognosis. HS can present with either isolated organ involvement or multi-systemic disease. This case series reports on nine patients with diverse clinical presentations and outcomes.Methods
Diagnoses of HS were confirmed using immunohistochemistry, with markers such as CD68 and lysozyme. Treatment primarily involved anthracycline-based chemotherapy with autologous hematopoietic stem cell transplantation (auto-HSCT) consolidation, and with salvage therapies for resistant or relapsed cases including allogeneic HSCT (allo-HSCT).Results
Despite intensive treatment, long-term remission was rare. Among the nine patients, three achieved complete remission but relapsed, three
SUBMITTER: Nam H
PROVIDER: S-EPMC11891036 | biostudies-literature | 2025
REPOSITORIES: biostudies-literature